Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines

Vaccine

Volumn 29, Issue 52, 2011, Pages 9668-9674

  Liang, Zhenglun ^a   Mao, Qunying ^a   Gao, Qiang ^b   Li, Xiuling ^c   Dong, Chenghong ^d   Yu, Xiang ^e   Yao, Xin ^a   Li, Fengxiang ^a   Yin, Weidong ^b   Li, Qihan ^d   Shen, Xinliang ^c   Wang, Junzhi ^a  

^a NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

^b Sinovac Biotech Co Ltd   (China)

^c NATIONAL VACCINE AND SERUM INSTITUTE   (China)

^d INSTITUTE OF MEDICAL BIOLOGY   (China)

^e Hualan Biological Engineering Inc   (China)

Author keywords

Antigen; Enterovirus 71 (EV71); Neutralizing antibody (NTAb); Vaccine

Indexed keywords

ENTEROVIRUS 71 VACCINE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHINA; CONTROLLED STUDY; COXSACKIE VIRUS A; DRUG SCREENING; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; FEMALE; HAND FOOT AND MOUTH DISEASE; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STANDARD; VIRUS STRAIN;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIGENS, VIRAL; CHINA; ENTEROVIRUS A, HUMAN; FEMALE; HAND, FOOT AND MOUTH DISEASE; HUMANS; MICE; REFERENCE STANDARDS; TECHNOLOGY, PHARMACEUTICAL; VIRAL VACCINES;

EID: 82555168284     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.10.018     Document Type: Article

References (29)

1. Schmidt N.J., Lennette E.H., Ho H.H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 1974, 129:304-309.
2. Chang L.Y., Lin T.Y., Huang Y.C., Tsao K.C., Shih S.R., Kuo M.L., et al. Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatr Infect Dis J 1999, 18:1092-1096.
3. Monto Ho. Enterovirus 71: the virus, its infections and outbreaks. J Microbiol Immunol Infect 2000, 33:205-216.
4. National notifiable diseases announced by Ministry of Health of the People's Republic of China. http://roll.sohu.com/20110527/n308684613.shtml.
5. Ong K.C., Devi S., Cardosa M.J., Wong K.T. Formaldehyde-inactivated hole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol 2010, 84:661-665.
6. http://roll.sohu.com/20110527/n308684613.shtml.
7. Liang Z.L. The study on candidate stains and standards of entervirus 71 vaccine. Chin J Viral Dis 2011, 1(1):24-27.
8. Xu J., Qian Y., Wang S., Serrano J.M., Li W., Huang Z., et al. EV71: an emerging infectious disease vaccine target in the Far East?. Vaccine 2010, 28:3516-3521.
9. Jia H., Cai F., Gao Q., Zhang J.S., Jing S.R. Development of a quantitative ELISA method for EV71 antigen. Chin J Biol 2010, 23(1):87-90.
10. Long R.X., Xie Z.P., Yang R., Li H., Bai H.Z., Dong C.H., et al. Development and application of BA-ELISA method for EV71 antigen. Chin J Biol 2009, 22(12):1230-1232.
11. Pharmacopoeia of the People's Republic of China. Beijing, China: Chinese Pharmacopoeia Commission, General Notices, Requirements for Preparation and Calibration of National Standard Substances of Biologics. 2005; III: p. 5-7.
12. World Health Organization. Recommendtions for the preparation, characterization and establishment of international and other biological reference standards (Revis2nd edn004). p. 45-52.
13. Yin-Murphy M., Tan K.L., Lim G.N., Quek J.H., Ishak B., Phoon M.C. Poliovirus neutralizing antibody in infants and cord blood. Ann Acad Med Singapore 1993, 22(3):281-285.
14. Grandien M., Fosgren M., Ehrnet A. Enterovirus. Diagnostic procedures for viral, rickettsial and chlamydial infections 1995, 279-298. American Public Health Association, Washington, DC. 7th edn. E.H. Lennette, D.A. Lennette, E.T. Lennette (Eds.).
15. Brown B.A., Oberste M.S., Alexander J.P., Kennett M.L., Pallansch M.A. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol 1999, 73:9969-9975.
16. Chua B.H., Phuektes P., Sanders S.A., Nicholls P.K., McMinn P.C. The molecular basis of mouse adaptation by human enterovirus 71. J Gen Virol 2008, 89(Pt 7):1622-1632.
17. Wu C.N., Lin Y.C., Fann C., Liao N.S., Shih S.R., Ho M.S. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 2001, 20:895-904.
18. Chung Y.C., Huang J.H., Lai C.W., Sheng H.C., Shih S.R., Ho M.S., et al. Expression, purification and characterization of enterovirus-71 virus-like particles. World J Gastroenterol 2006, 12(6):921-927.
19. Chung Y.C., Ho M.S., Wu J.C., Chen W.J., Huang J.H., Chou S.T., et al. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 2008, 26:1855-1862.
20. Foo D.G., Alonso S., Phoon M.C., Ramachandran N.P., Chow V.T., Poh C.L. Identification of neutralizing linear epitopes from the VP1 capsid protein of enterovirus 71 using synthetic peptides. Virus Res 2007, 125:61-68.
21. Foo D.G., Alonso S., Chow V.T., Poh C.L. Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Microbes Infect 2007, 9:1299-1306.
22. Tung W.S., Bakar S.A., Sekawi Z., Rosli R. DNA vaccine constructs against enterovirus 71 elicit immune response in mice. Genet Vaccines Ther 2007, 5:6.
23. Lee M.S., Chang L.Y. Development of enterovirus 71 vaccines. Expert Rev Vaccines 2010, 9(2):149-156.
24. Yu C.K., Chen C.C., Chen C.L., Wang J.R., Liu C.C., Yan J.J., et al. Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J Biomed Sci 2000, 7:523-528.
25. Liu C.C., Lian W.C., Butler M., Wu S.C. High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture. Vaccine 2007, 25:19-24.
26. Sanden S.V.D., Avoort H.V.D., Lemey P., Uslu G., Koopmans M. Evolutionary trajectory of the VP1 gene of human enterovirus 71 genogroup B and C virus. J Gen Virol 2010, 91(Pt 8):1949-1958.
27. Arita M., Nagata N., Iwata N., Ami Y., Suzaki Y., Mizuta K., et al. An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J Virol 2007, 81:9386-9395.
28. Mizuta K., Aoki Y., Suto A., Ootani K., Katsushima N., Itagaki T., et al. Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007. Vaccine 2009, 27(24):3153-3158.
29. World Health Organisation. Manual for the virological investigation of polio; 1997, p. 50.